Abstract
An independent clinical trial of the Penn seroflocculation test for cancer was carried out in order to learn whether this test might be clinically useful either in differential diagnosis or as a screening test for the detection of cancer. In addition, studies were made of the flocculation titer of sera giving positive Penn tests. Incidental observations were made concerning the reproducibility of the test.
The trial provided no evidence that the test might be useful in cancer detection.
The test should be improved technologically before further clinical evaluations are undertaken.
Further study of the basic mechanisms that bring about the positive Penn reaction appears desirable.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DUNN J. E., Jr, GREENHOUSE S. W. The development and evaluation of cancer diagnostic tests. Public Health Rep. 1953 Sep;68(9):880–884. [PMC free article] [PubMed] [Google Scholar]
- HALL G. C., DOWDY A. H., PENN H. S., BELLAMY A. W. Tumor lipoids. II. Clinical evaluation of a serologically active nonsaponifiable fraction of liver of cancer-bearing patients. J Natl Cancer Inst. 1952 Jun;12(6):1399–1416. [PubMed] [Google Scholar]
- PENN H. S. Tumor lipoids. I. Preparation of a serologically active nonsaponifiable fraction of liver of cancer bearing patients. J Natl Cancer Inst. 1952 Jun;12(6):1389–1399. [PubMed] [Google Scholar]
- SPRUNT D. H., HALE W. M., CHANG F. C., RICHMOND S. G., ERICKSON C. C. Present status of cancer tests. Science. 1955 Aug 12;122(3163):273–274. doi: 10.1126/science.122.3163.273. [DOI] [PubMed] [Google Scholar]